We are committed to serving the best interests of our shareholders.

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary TESARO Announces Election of Dr. James Armitage to Board of Directors and Results of Annual Stockholder Meeting
WALTHAM, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced that James O. Armitage, M.D., F.A.C.P., F.R.C.P., has been elected to the TESARO Board of Directors. This election increases the number of independent directors
View HTML
Toggle Summary Tesaro Announces First-Quarter 2013 Operating Results
Phase 3 Trial of Niraparib in Breast Cancer to be Initiated in the Second Half of 2013 Phase 3 Trial of Niraparib in Ovarian Cancer on Track to Begin Enrolling Mid-2013 Top-Line Results of Rolapitant Phase 3 Program to be Announced in the Second Half of 2013 Fifth Dose Level Achieved in Phase 1/2
View HTML
Toggle Summary TESARO to Announce First Quarter 2013 Financial Results on April 25, 2013
WALTHAM, Mass., April 17, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) will announce its first quarter 2013 financial results on Thursday, April 25, 2013, after the close of the U.S. financial markets. TESARO's senior management will host a conference call and live audio webcast on Thursday,
View HTML
Toggle Summary TESARO to Present at the 20th Annual Future Leaders in the Biotech Industry Conference
WALTHAM, Mass., March 28, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and Chief Scientific Officer, will present at the 20 th Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel and Conference
View HTML
Toggle Summary TESARO Announces Closing of Public Offering and Full Exercise of Over-Allotment Option by Underwriters
WALTHAM, Mass., March 5, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today the closing of its previously announced underwritten public offering of common stock. The total number of shares of common stock sold was 5,428,000, composed of 4,720,000 shares of common stock initially
View HTML
Toggle Summary TESARO Announces Pricing of Upsized Public Offering of Common Stock
WALTHAM, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has priced an underwritten public offering of an aggregate of 4,720,000 shares of its common stock at a price to the public of $18.00 per share. The gross proceeds from the offering will be
View HTML
Toggle Summary TESARO Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has commenced an underwritten public offering of $75 million of its common stock. In connection with this offering, TESARO plans to grant the underwriters an option to purchase up to an additional
View HTML
Toggle Summary TESARO Announces Fourth Quarter and Year-End 2012 Operating Results
Niraparib to be Advanced in a Phase 3 Pivotal Trial for Ovarian Cancer Enrollment Continues in the Global Registration Program for Rolapitant Achieved Third Dose-level in a Phase 1/2 Clinical Trial of TSR-011 WALTHAM, Mass., Feb. 14, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc.
View HTML
Toggle Summary TESARO to Announce Fourth Quarter and Year End 2012 Financial Results on Thursday, February 14th, 2013
WALTHAM, Mass., Feb. 11, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) will announce its fourth quarter and year end 2012 financial results on Thursday, February 14 th , 2013, before the opening of the U.S. financial markets. TESARO's senior management will host a conference call and live
View HTML
Toggle Summary TESARO to Present at the Leerink Swann Global Healthcare Conference
WALTHAM, Mass., Feb. 6, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, Chief Executive Officer, and Mary Lynne Hedley, Ph.D., President and Chief Scientific Officer, will present at the Leerink Swann Global Healthcare Conference at the Waldorf Astoria Hotel
View HTML